Alkermes plc Stock Analysis & AI Score
Alkermes plc (ALKS) has an ST Score of 55.2 (B-), driven by its Profitability (A+) and held back by its Valuation (D). Analysts rate it Buy with a $58.83 price target (+44.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Alkermes plc (ALKS) has an ST Score of 55.2 (B-), driven by its Profitability (A+) and held back by its Valuation (D). Analysts rate it Buy with a $58.83 price target (+44.2% upside).
- Strongest
- ProfitabilityA+
- Weakest
- ValuationD
All factor grades
- ProfitabilityA+
- SentimentA+
- GrowthB
- MomentumB-
- ForecastC+
- Financial StrengthD+
- ValuationD
- Piotroski4/9
Contact
ALKS stock: frequently asked questions
What is ALKS's ST Score?
Alkermes plc (ALKS) has an ST Score of 55.2 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ALKS a buy, hold, or sell?
Analysts rate ALKS a Buy, with a price target of $58.83 (+44.2% vs the current price). Our ST Score grades it B- (55.2/100). The ST Score is a data-driven signal, not a recommendation.
What are ALKS's factor grades?
Valuation D, Profitability A+, Financial Strength D+, Momentum B-, Growth B, Forecast C+, Sentiment A+.
What is ALKS's valuation grade?
Alkermes plc (ALKS) earns a valuation grade of D, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ALKS's growth grade?
Alkermes plc (ALKS) earns a growth grade of B, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ALKS's profitability grade?
Alkermes plc (ALKS) earns a profitability grade of A+, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ALKS's financial strength grade?
Alkermes plc (ALKS) earns a financial strength grade of D+, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ALKS?
The average analyst price target for Alkermes plc (ALKS) is $58.83 from 29 analysts, which is +44.2% versus the recent price of $40.79.
What is ALKS's Piotroski score?
Alkermes plc (ALKS) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.